Featured Article

Rheumatoid Arthritis and CKD Risks and Causes HealthTree for Kidney fresh ideas for 2026

Heather Aug 05, 2026

Rheumatoid Arthritis and CKD Risks and Causes

Rheumatoid Arthritis and CKD Risks and Causes HealthTree for Kidney
Rheumatoid Arthritis and CKD Risks and Causes HealthTree for Kidney

1 in 4 people with RA develop CKD . Learn how chronic inflammation and high disease activity damage your kidneys , which RA medications are safe.

The Impact of GLP 1 Receptor Agonists on Ocular Disease
The Impact of GLP 1 Receptor Agonists on Ocular Disease

There have been few large population-based studies of the association between rheumatoid arthritis (RA) and chronic kidney disease ( CKD ) and glomerulonephritis. This nationwide cohort study investigated the risks of developing CKD and ...

The Interplay Between Rheumatoid Arthritis and Chronic Kidney Disease ...

Mechanisms of Action of GLP 1 RAs
Mechanisms of Action of GLP 1 RAs

Chronic kidney disease ( CKD ) is a frequent and clinically significant comorbidity in patients with rheumatoid arthritis (RA), with a reported prevalence ranging from 20% to 50% depending on the cohort and definition applied. The high burden of CKD in RA reflects the complex interplay between traditional risk factors (aging, hypertension, diabetes, and dyslipidemia) and RA-specific factors such ...

What was known: Rheumatoid arthritis (RA) has been associated with an increased risk of chronic kidney disease ( CKD ), but the predominant renal phenotype in RA remained unclear. Prior studies suggested that systemic inflammation and comorbidities may contribute to kidney impairment in RA. It was uncertain whether RA independently increases CKD risk after accounting for cardiovascular and ...

GLP 1 Receptor Agonists in the Treatment of Patients with Type 2
GLP 1 Receptor Agonists in the Treatment of Patients with Type 2

Disease activity of rheumatoid arthritis and kidney function decline

Introduction Chronic kidney disease ( CKD ) is a common comorbidity of rheumatoid arthritis (RA). The association of longitudinal RA disease activity with long-term kidney function has remained uncertain. Method We analysed a multicentre prospective RA registry in the USA from 2001 to 2022. The exposure was updated time-averaged Clinical Disease Activity Index (TA-CDAI) categories from study ...

Abstract Recent evidence indicates an increased risk of chronic kidney disease ( CKD ) in patients with rheumatoid arthritis (RA), with prevalence rates ranging from 20.8% to 24.5%. Risk factors for CKD among RA patients include advancing age, diabetes, cardiovascular disease, hypertension and RA disease activity. Medications such as glucocorticoids and nonsteroidal anti-inflammatory drugs ...

GLP 1 receptor agonists GLP 1RAs cardiovascular actions
GLP 1 receptor agonists GLP 1RAs cardiovascular actions

Disease activity of rheumatoid arthritis and kidney function decline

Chronic kidney disease ( CKD ) is a common comorbidity of rheumatoid arthritis (RA). The association of longitudinal RA disease activity with long-term kidney function has remained uncertain.

Learn about the link between Rheumatoid Arthritis (RA) and the increased risk of serious kidney disease, and how to protect yourself.

GLP 1 Receptor Agonists and Diabetic Kidney Disease A Game Charger
GLP 1 Receptor Agonists and Diabetic Kidney Disease A Game Charger

Rheumatoid arthritis and kidney disease

Chronic inflammation with rheumatoid arthritis can damage the kidneys and may increase the risk of kidney disease. Read more about the risk .

Frontiers
Frontiers
PDF Effects of GLP 1 Receptor Agonists on Cardiovascular Outcomes
PDF Effects of GLP 1 Receptor Agonists on Cardiovascular Outcomes
GLP 1 receptor agonists reduce kidney failure risk and cardiovascular
GLP 1 receptor agonists reduce kidney failure risk and cardiovascular
SGLT2 Inhibitors and GLP 1 Receptor Agonists in Kidney Transplantation
SGLT2 Inhibitors and GLP 1 Receptor Agonists in Kidney Transplantation

Increased rheumatoid arthritis (RA) disease activity is linked to faster estimated glomerular filtration rate (eGFR) decline and a higher risk for significant kidney dysfunction, according to study results published in Annals of the Rheumatic Diseases.